Cancer Epidemiology Biomarkers & Prevention, Vol 5, Issue 4 253-261, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China

JS Wang, GS Qian, A Zarba, X He, YR Zhu, BC Zhang, L Jacobson, SJ Gange, A Munoz and TW Kensler
Department of Environmental Health Sciences, School of Hygiene and Public Health, Johns Hopkins University, Baltimore, Maryland 21205, USA.

Molecular epidemiological studies of populations at high risk for liver cancer have shown that hepatitis B virus (HBV) and aflatoxin B1 (AFB1) exposure are two major risk factors for this disease. These etiological agents, combined with nutritional deficiencies, are important for the initiation and promotion of liver cancer in various parts of the world. In Qidong, People's Republic of China, liver cancer accounts for 10% of all adult deaths, and both HBV and AFB1 exposures are common. To study temporal and possible chemical-viral interactions in people, serum samples were collected during a longitudinal study designed to measure aflatoxin molecular biomarkers in residents of Daxin Township, Qidong City, People's Republic of China. In this study, the temporal modulation of aflatoxin adduct formation with albumin over multiple lifetimes of serum albumin was examined in both HBV-positive and HBV-negative people in two periods: September-December 1993 (wave 1) and June-September 1994 (wave 2). During the 12-week monitoring period of wave 1, 120 individuals (balanced by gender and HBV status) provided a total of 792 blood samples. AFB1-albumin adducts were detected in all but one of the serum samples. The range of binding detected by RIA in the Daxin population was 0.17-4.39 pmol AFB11/mg albumin with an overall mean +/- SD of 1.51 +/- 0.21 pmol AFB11/mg albumin. The mean +/- SD for weeks 0, 2, 4, 6, 8, 10 and 12 of wave 1 were 1.21 +/- 0.41, 1.58 +/- 0.70, 1.36 +/- 0.52, 1.71 +/- 0.44, 1.18 +/- 0.60, 2.00 +/- 0.59, and 1.68 +/- 0.34 pmol AFB1/mg albumin, respectively. During wave 2, 103 individuals from wave 1 provided a total of 396 blood samples collected monthly over wave 2, with mean +/- SD aflatoxin-albumin adduct levels of 1.19 +/- 0.37, 0.85 +/- 0.45, 0.89 +/- 0.28, and 0.61 +/- 0.15 pmol AFB1/mg albumin. Using linear regression models, the mean aflatoxin-albumin adduct levels increased (P < 0.05) during the 12 weeks of wave 1 and decreased (P < 0.05) over the 4 months of wave 2. Neither HBV surface antigen status nor gender modified either the baseline mean or the temporal trend. High-performance liquid chromatography confirmation was done on a subset of serum samples, and the results show an excellent association between the immunoassay data and high-performance liquid chromatography. Taken together, these data demonstrate that AFB1-albumin is a sensitive and specific biomarker for assessing exposure to this carcinogen in the population in Qidong.

This article has been cited by other articles:

				L. F. McCoy, P. F. Scholl, A. E. Sutcliffe, S. M. Kieszak, C. D. Powers, H. S. Rogers, Y. Y. Gong, J. D. Groopman, C. P. Wild, and R. L. Schleicher Human Aflatoxin Albumin Adducts Quantitatively Compared by ELISA, HPLC with Fluorescence Detection, and HPLC with Isotope Dilution Mass Spectrometry Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1653 - 1657. [Abstract] [Full Text] [PDF]

				L. Tang, M. Tang, L. Xu, H. Luo, T. Huang, J. Yu, L. Zhang, W. Gao, S. B. Cox, and J.-S. Wang Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention Carcinogenesis, February 1, 2008; 29(2): 411 - 417. [Abstract] [Full Text] [PDF]

				T. Peng, L.-Q. Li, M.-H. Peng, Z.-M. Liu, T.-W. Liu, Y. Guo, K.-Y. Xiao, Z. Qin, X.-P. Ye, X.-S. Mo, et al. Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1 a multi-center and multi-biomarker study Carcinogenesis, November 1, 2007; 28(11): 2347 - 2354. [Abstract] [Full Text] [PDF]

				T. W. Kensler, J.-G. Chen, P. A. Egner, J. W. Fahey, L. P. Jacobson, K. K. Stephenson, L. Ye, J. L. Coady, J.-B. Wang, Y. Wu, et al. Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2605 - 2613. [Abstract] [Full Text] [PDF]

				Y. Jiang, P. E. Jolly, W. O. Ellis, J.-S. Wang, T. D. Phillips, and J. H. Williams Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians Int. Immunol., June 1, 2005; 17(6): 807 - 814. [Abstract] [Full Text] [PDF]

				J. H Williams, T. D Phillips, P. E Jolly, J. K Stiles, C. M Jolly, and D. Aggarwal Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1106 - 1122. [Abstract] [Full Text] [PDF]

				S.-Y. Kuang, P. E. Jackson, J.-B. Wang, P.-X. Lu, A. Munoz, G.-S. Qian, T. W. Kensler, and J. D. Groopman Specific mutations of hepatitis B virus in plasma predict liver cancer development PNAS, March 9, 2004; 101(10): 3575 - 3580. [Abstract] [Full Text] [PDF]

				C.P. Wild and P.C. Turner The toxicology of aflatoxins as a basis for public health decisions Mutagenesis, November 1, 2002; 17(6): 471 - 481. [Abstract] [Full Text] [PDF]

				E. Le Ferrec, D. Lagadic-Gossmann, C. Rauch, C. Bardiau, K. Maheo, F. Massiere, M. Le Vee, A. Guillouzo, and F. Morel Transcriptional Induction of CYP1A1 by Oltipraz in Human Caco-2 Cells Is Aryl Hydrocarbon Receptor- and Calcium-dependent J. Biol. Chem., June 28, 2002; 277(27): 24780 - 24787. [Abstract] [Full Text] [PDF]

				S.-Y. Chen, C.-J. Chen, S.-R. Chou, L.-L. Hsieh, L.-Y. Wang, W.-Y. Tsai, H. Ahsan, and R. M. Santella Association of Aflatoxin B1-Albumin Adduct Levels with Hepatitis B Surface Antigen Status among Adolescents in Taiwan Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1223 - 1226. [Abstract] [Full Text] [PDF]

				A. Camoirano, M. Bagnasco, C. Bennicelli, C. Cartiglia, J.-B. Wang, B.-C. Zhang, Y.-R. Zhu, G.-S. Qian, P. A. Egner, L. P. Jacobson, et al. Oltipraz Chemoprevention Trial in Qidong, People's Republic of China: Results of Urine Genotoxicity Assays as Related to Smoking Habits Cancer Epidemiol. Biomarkers Prev., July 1, 2001; 10(7): 775 - 783. [Abstract] [Full Text] [PDF]

				J.-S. Wang, S. Abubaker, X. He, G. Sun, P. T. Strickland, and J. D. Groopman Development of Aflatoxin B1-Lysine Adduct Monoclonal Antibody for Human Exposure Studies Appl. Envir. Microbiol., June 1, 2001; 67(6): 2712 - 2717. [Abstract] [Full Text]

				J.-S. Wang, T. Huang, J. Su, F. Liang, Z. Wei, Y. Liang, H. Luo, S.-Y. Kuang, G.-S. Qian, G. Sun, et al. Hepatocellular Carcinoma and Aflatoxin Exposure in Zhuqing Village, Fusui County, People's Republic of China Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 143 - 146. [Abstract] [Full Text]

				S. S. Wang, J.P. O'Neill, G.-S. Qian, Y.-R. Zhu, J.-B. Wang, H. Armenian, A. Zarba, J.-S. Wang, T. W. Kensler, N. F. Cariello, et al. Elevated HPRT mutation frequencies in aflatoxin-exposed residents of Daxin, Qidong County, People's Republic of China Carcinogenesis, November 1, 1999; 20(11): 2181 - 2184. [Abstract] [Full Text] [PDF]

				J. D. Groopman and T. W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis, January 1, 1999; 20(1): 1 - 11. [Full Text] [PDF]